Presenters and a panel discuss leveraging model integrated evidence for long-acting injectables (LAIs) to reduce regulatory barriers. Presentation titles include, “Model Integrated Methods for Generic LAI Product Development and Regulatory Assessment: Current Status and Future Research Directions” and “How Can Model Integrated Evidence Accelerate LAI Generic Availability?”
Learn more at: [ Ссылка ]
_______________________________ 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  
 
Upcoming Training - [ Ссылка ]
SBIA Listserv - [ Ссылка ]
SBIA 2021 Playlist - [ Ссылка ]
SBIA LinkedIn: [ Ссылка ]
SBIA Training Resources - [ Ссылка ]
Twitter - [ Ссылка ]
Email - CDERSBIA@fda.hhs.gov  
Phone - (301) 796-6707 I (866) 405-5367

свернуть